IRIS
GIULIANI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.302
AS - Asia 14.715
EU - Europa 9.128
SA - Sud America 1.832
AF - Africa 803
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 7
Totale 41.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.804
SG - Singapore 5.260
CN - Cina 4.132
VN - Vietnam 2.235
IE - Irlanda 1.616
SE - Svezia 1.517
BR - Brasile 1.431
IT - Italia 1.207
FI - Finlandia 1.133
HK - Hong Kong 994
DE - Germania 954
UA - Ucraina 647
BD - Bangladesh 591
FR - Francia 564
ZA - Sudafrica 537
TR - Turchia 524
NL - Olanda 416
CA - Canada 326
GB - Regno Unito 302
IN - India 233
RU - Federazione Russa 182
AR - Argentina 157
AT - Austria 121
JP - Giappone 93
MX - Messico 93
CI - Costa d'Avorio 90
IQ - Iraq 82
KR - Corea 72
RO - Romania 69
ES - Italia 66
BE - Belgio 65
PL - Polonia 65
CZ - Repubblica Ceca 58
EC - Ecuador 58
PH - Filippine 58
PK - Pakistan 56
TH - Thailandia 53
CO - Colombia 44
ID - Indonesia 44
VE - Venezuela 41
UZ - Uzbekistan 39
MA - Marocco 37
LT - Lituania 35
PY - Paraguay 27
CL - Cile 24
TW - Taiwan 24
AE - Emirati Arabi Uniti 23
SA - Arabia Saudita 23
EG - Egitto 22
KE - Kenya 21
IR - Iran 20
UY - Uruguay 20
EU - Europa 18
JO - Giordania 18
MY - Malesia 18
PE - Perù 18
CR - Costa Rica 17
ET - Etiopia 17
TN - Tunisia 17
IL - Israele 16
KZ - Kazakistan 15
BG - Bulgaria 14
AL - Albania 13
JM - Giamaica 13
BO - Bolivia 12
NP - Nepal 12
CH - Svizzera 10
DZ - Algeria 9
OM - Oman 9
SN - Senegal 9
DO - Repubblica Dominicana 8
HN - Honduras 8
HU - Ungheria 8
LV - Lettonia 8
PT - Portogallo 8
QA - Qatar 8
LB - Libano 7
NG - Nigeria 7
PA - Panama 7
AM - Armenia 6
AZ - Azerbaigian 6
MD - Moldavia 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
GA - Gabon 5
GT - Guatemala 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AO - Angola 4
AU - Australia 4
BW - Botswana 4
BY - Bielorussia 4
EE - Estonia 4
GR - Grecia 4
HR - Croazia 4
KG - Kirghizistan 4
KH - Cambogia 4
KW - Kuwait 4
LU - Lussemburgo 4
Totale 41.728
Salva come PNG Salva come JPEG
Città #
Singapore 2.625
Ashburn 1.802
Chandler 1.638
Dublin 1.609
San Jose 1.459
Beijing 1.019
Hong Kong 933
Santa Clara 906
Dallas 876
Jacksonville 763
Ho Chi Minh City 666
Hanoi 516
Boardman 515
Johannesburg 509
Nanjing 410
Izmir 405
Parma 395
Dearborn 382
Los Angeles 372
Ann Arbor 346
New York 332
Princeton 322
Shanghai 320
Lauterbourg 316
San Mateo 233
Munich 214
Wilmington 187
Toronto 174
Shenyang 159
Hefei 156
Kunming 147
Marseille 140
Buffalo 139
São Paulo 138
Nanchang 137
Helsinki 135
Düsseldorf 125
Jinan 106
Columbus 105
Hebei 105
Vienna 99
Moscow 97
Da Nang 95
Abidjan 90
Council Bluffs 90
Haiphong 90
Des Moines 88
Tianjin 86
Jiaxing 78
Turku 78
The Dalles 76
Seattle 75
Bremen 74
Tokyo 72
Milan 71
Changsha 66
Brussels 64
Orem 64
Montreal 59
Warsaw 56
Woodbridge 54
Houston 53
Kocaeli 52
Brooklyn 51
Guangzhou 50
Phoenix 50
London 49
Seoul 49
Frankfurt am Main 47
Hangzhou 46
Pune 46
Rio de Janeiro 46
Atlanta 44
Rome 43
Bologna 41
Hải Dương 41
Nuremberg 41
Chicago 40
Poplar 40
Stockholm 40
Amsterdam 39
Focsani 39
Brno 37
Norwalk 37
Biên Hòa 36
Tashkent 35
Zhengzhou 35
Can Tho 34
Denver 34
Chennai 33
San Francisco 33
Boston 30
Grafing 29
Ankara 27
Naples 27
Dhaka 26
Mexico City 26
Belo Horizonte 25
Baghdad 24
Manchester 24
Totale 24.957
Salva come PNG Salva come JPEG
Nome #
Angiopoietin-1 and Osteopontin Expression by CD138+ Myeloma Cells Rather Than VEGF and CD45 Correlates with Bone Marrow Angiogenesis in Multiple Myeloma Patients at the Diagnosis 227
Are the Myeloma bone microevironment cells tumoral or not? 224
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 221
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 220
Bone marrow CX3CL1/Fractalkine is a new player of the pro-angiogenic microenvironment in multiple myeloma patients 215
A simplified sars-cov-2 pseudovirus neutralization assay 211
(2S,4R)-4-fluoroglutamine is converted into (2S,4R)-4-fluoroglutamate by glutaminase activity and may be exploited as a PET tracer in glutamine-addicted cancers 211
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment 206
[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma 206
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 203
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 199
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients 196
CD14+CD16+ monocytes are involved in daratumumab-mediated myeloma cells killing and in anti-CD47 therapeutic strategy 196
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 195
Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo 193
Novel targets for the treatment of relapsing multiple myeloma 192
The Proteasome and Myeloma-Associated Bone Disease 191
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 191
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 188
Role of 1q21 in multiple myeloma: From pathogenesis to possible therapeutic targets 188
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 185
Activation of non-canonical wnt pathway in human mesenchymal cells affects osteogenic differentiation: a potential target in Multiple Myeloma microenvironment 184
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 184
CC-4047 (Pomalidomide) inhibits multiple myeloma-induced osteoclast formation targeting RANKL in the bone marrow microenvironment 183
Hypoxia and hypoxia inducible factor (HIF)-1α in Multiple Myeloma patients: role in the angiogenic switch 183
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 183
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 182
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 182
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 182
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 179
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia 178
HOXB7 is a key gene involved in Myeloma cell growth and Myeloma-induced angiogenesis in Multiple Myeloma patients 177
Hypoxia and Hypoxia Inducible Factor (HIF)-1{alpha} in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment 175
Bisphosphonates inhibit IL-6 production by human osteoblast-like cells 174
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 174
5-HT3 serotonergic receptor mediation of hypoglycemia-induced arginine-vasopressin but not oxytocin secretion in normal men. 173
Angiopoietin-1 and osteopontin expression by CD138+myeloma cells rather than VEGF and CD45 correlates with bone marrow angiogenesis in Multiple Myeloma patients at the diagnosis. 172
Chemokine receptors CXCR3 and CXCR4 expression in B cell and plasma cell malignancy 171
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 169
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules 168
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 168
Oxygen tension in the bone marrow (BM) of patients with malignant and indolent monoclonal gammopathy: role of hypoxia and hypoxia-inducible factor (HIF)-1{alpha} in the regulation of gene expression and pro-angiogenic profiles of CD138+ cells 167
ADENOSINE IN THE MYELOMA BONE MARROW NICHE: IMMUNE CHECKPOINT AND KEY PLAYER IN DISEASE PROGRESSION 167
Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes 166
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma 164
Functional consequences of low activity of transport system a for neutral amino acids in human bone marrow mesenchymal stem cells 162
Myeloma cells inhibit the non-canonical wnt co-receptor ror2 in human mesenchymal/osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on mm-induced impairment of the osteogenic differentiation process 161
A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors 160
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 160
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 160
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 159
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 159
HOXB7 is critically involved in Multiple Myeloma-induced angiogenic switch 158
A Mouse Model of Telomere Dysfunction Recapitulates Hallmark Features of Human Myelodysplastic Syndrome 158
The homeobox gene HOXB7 regulates the production of pro-angiogenic molecole by myeloma cells and it is a target in myeloma-induced angiogenesis 157
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 157
A translocation t(4;13)(q21;q14) as single clonal chromosomal abnormality in a parathyroid adenoma 157
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 157
Angiopoietins expression by human myeloma cells 156
CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. 156
GPNA inhibits the sodium-independent transport system l for neutral amino acids 156
Bone marrow endothelial cells carry bcr/abl fusion gene from chronic myeloid leukemia patients 156
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 156
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 154
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 154
Amlexanox inhibition of TBK1/IKK epsilon Signaling Is a Novel Therapeutic Approach for Multiple Myeloma-Induced Bone Disease. 154
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 153
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation 152
In vitro and In vivo evidences of osteocytes involvement in myeloma-induced osteolysis 152
Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy 152
Angiogenic switch in multiple myeloma patients 151
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 151
Autologous bone marrow transplantation in acute myeloid leukemia: a single center experience 150
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking 149
CC-Chemokine Ligand 20/Macrophage Inflammatory Protein-3A and CC-Chemokine Receptor 6 Are Overexpressed in Myeloma Microenvironment Related to Osteolytic Bone Lesions 148
Hematologic malignancies with extramedullary spread of disease. Case 1. Multiple myeloma with extramedullary involvement of the pleura and testes 148
Glutamine dependence and PIK3CA mutations in colon-rectal cancer cells: ATF4 enters the stage 148
Phase II Study of the Combination of Interleukin-2 with Zoledronic Acid As Maintenance Therapy Following Autologous Stem Cell Transplant in Patients with Multiple Myeloma 148
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 148
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 148
Angiogenic properties of human myeloma cells: role of angiopoietin system 147
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 147
Non canonical wnt signal pathway (Wnt5a/ror2) activation stimulates the osteogenic differentiation process of bone mesenchymal cells being a potential target in multiple myeloma bone disease 147
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 147
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 146
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 146
Pro-angiogenetic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship with myeloma-induced angiogenesis 145
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma. 145
Clinicians’ Perspectives and Methodological Application of Fluorescence in situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report From the European Myeloma Network (EMN) Italy 144
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 144
Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies 144
BCR/ABL fusion gene is detected in chronic myeloid leukemia endothelial cells 144
Increased osteocyte apoptosis in Multiple Myeloma patients: a potential role in bone remodeling alterations related to osteolytic bone lesions 143
Ectopic production of osteopontin by human myeloma cells and its involvement in myeloma induced angiogenesis 143
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 143
Angiogenesis and multiple myeloma 143
Analysis of lineage involvment in Philadelphia chromosome positive acute lymphoblastic leukaemia 142
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 142
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 141
Totale 16.765
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/20221.588 31 23 26 110 37 57 199 202 77 145 128 553
2022/20236.236 723 644 385 451 531 669 158 398 1.953 74 185 65
2023/20242.278 110 237 55 57 190 623 194 163 54 125 152 318
2024/20257.370 117 402 434 583 797 686 288 319 978 668 632 1.466
2025/202616.855 1.425 1.465 2.034 1.513 2.345 953 1.717 601 2.150 1.322 780 550
Totale 42.270